Literature DB >> 30395767

LncRNA SNHG5 affects cell proliferation, metastasis and migration of colorectal cancer through regulating miR-132-3p/CREB5.

Mingbao Zhang1, Yue Li2, Hongbo Wang1, Weihua Yu1, Sen Lin1, Jianqiang Guo1.   

Abstract

We aimed at the effects of long non-coding RNA (lncRNA) SNHG5 on proliferation, metastasis and migration of colorectal cancer (CRC) cells. We also investigated regulatory relationships among miR-132-3p, SNHG5 and CREB5 and their roles in CRC. 25 pairs of samples containing CRC tissues and matched para-tumor tissues were obtained to examine SNHG5, miR-132-3p and CREB5 expression by qRT-PCR or Western blot. The targeted relationship between miR-132-3p and SNHG5 or CREB5 was confirmed by dual luciferase report assay as well as RNA pull down assay. The expression of SNHG5, miR-132-3p and CREB5 in CRC cells were regulated by cell transfection. CRC cellular proliferation was assayed by CCK-8 and meanwhile flow cytometry was adopted to observe apoptosis. Metastasis and migration of CRC cells were determined respectively by means of Transwell assay and scratch test. The effects of SNHG5 on CRC were researched in vivo, too. SNHG5 or CREB5 was up-regulated in CRC tissues and cells, whereas miR-132-3p was down-regulated. Overexpression of SNHG5 and CREB5 resulted in the enhancement of proliferation, metastasis, migration and the inhibition of apoptosis in CRC cells, while miR-132-3p led to the opposite result. LncRNA SNHG5 promoted proliferation, migration and metastasis of CRC cells but inhibited apoptosis by modulating miR-132-3p/CERB5.

Entities:  

Keywords:  LncRNA SNHG5; biomarker; colorectal cancer; genetics; miR-132-3p; proliferation

Mesh:

Substances:

Year:  2018        PMID: 30395767      PMCID: PMC6422517          DOI: 10.1080/15384047.2018.1537579

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  25 in total

1.  MiR-132 prohibits proliferation, invasion, migration, and metastasis in breast cancer by targeting HN1.

Authors:  Zhan-Guo Zhang; Wei-Xun Chen; Yan-Hui Wu; Hui-Fang Liang; Bi-Xiang Zhang
Journal:  Biochem Biophys Res Commun       Date:  2014-10-17       Impact factor: 3.575

2.  SnoRNA U50 is a candidate tumor-suppressor gene at 6q14.3 with a mutation associated with clinically significant prostate cancer.

Authors:  Xue-Yuan Dong; Carmen Rodriguez; Peng Guo; Xiaodong Sun; Jeffrey T Talbot; Wei Zhou; John Petros; Qunna Li; Robert L Vessella; Adam S Kibel; Victoria L Stevens; Eugenia E Calle; Jin-Tang Dong
Journal:  Hum Mol Genet       Date:  2008-01-17       Impact factor: 6.150

3.  Implication of snoRNA U50 in human breast cancer.

Authors:  Xue-Yuan Dong; Peng Guo; Jeff Boyd; Xiaodong Sun; Qunna Li; Wei Zhou; Jin-Tang Dong
Journal:  J Genet Genomics       Date:  2009-08       Impact factor: 4.275

4.  An Encapsulation of Gene Signatures for Hepatocellular Carcinoma, MicroRNA-132 Predicted Target Genes and the Corresponding Overlaps.

Authors:  Xin Zhang; Wei Tang; Gang Chen; Fanghui Ren; Haiwei Liang; Yiwu Dang; Minhua Rong
Journal:  PLoS One       Date:  2016-07-28       Impact factor: 3.240

5.  SNHG5 promotes colorectal cancer cell survival by counteracting STAU1-mediated mRNA destabilization.

Authors:  Nkerorema Djodji Damas; Michela Marcatti; Christophe Côme; Lise Lotte Christensen; Morten Muhlig Nielsen; Roland Baumgartner; Helene Maria Gylling; Giulia Maglieri; Carsten Friis Rundsten; Stefan E Seemann; Nicolas Rapin; Simon Thézenas; Søren Vang; Torben Ørntoft; Claus Lindbjerg Andersen; Jakob Skou Pedersen; Anders H Lund
Journal:  Nat Commun       Date:  2016-12-22       Impact factor: 14.919

6.  Down-Regulation of microRNA-132 is Associated with Poor Prognosis of Colorectal Cancer.

Authors:  Yukako Mokutani; Mamoru Uemura; Koji Munakata; Daisuke Okuzaki; Naotsugu Haraguchi; Hidekazu Takahashi; Junichi Nishimura; Taishi Hata; Kohei Murata; Ichiro Takemasa; Tsunekazu Mizushima; Yuichiro Doki; Masaki Mori; Hirofumi Yamamoto
Journal:  Ann Surg Oncol       Date:  2016-02-11       Impact factor: 5.344

7.  LncRNA profile study reveals a three-lncRNA signature associated with the survival of patients with oesophageal squamous cell carcinoma.

Authors:  Jiagen Li; Zhaoli Chen; Liqing Tian; Chengcheng Zhou; Max Yifan He; Yibo Gao; Suya Wang; Fang Zhou; Susheng Shi; Xiaoli Feng; Nan Sun; Ziyuan Liu; Geir Skogerboe; Jingsi Dong; Ran Yao; Yuda Zhao; Jian Sun; Baihua Zhang; Yue Yu; Xuejiao Shi; Mei Luo; Kang Shao; Ning Li; Bin Qiu; Fengwei Tan; Runsheng Chen; Jie He
Journal:  Gut       Date:  2014-02-12       Impact factor: 23.059

8.  MiR-582-5p/miR-590-5p targeted CREB1/CREB5-NF-κB signaling and caused opioid-induced immunosuppression in human monocytes.

Authors:  X Long; Y Li; S Qiu; J Liu; L He; Y Peng
Journal:  Transl Psychiatry       Date:  2016-03-15       Impact factor: 6.222

Review 9.  Long non-coding RNAs in colorectal cancer.

Authors:  Xia Xie; Bo Tang; Yu-Feng Xiao; Rui Xie; Bo-Sheng Li; Hui Dong; Jian-Yun Zhou; Shi-Ming Yang
Journal:  Oncotarget       Date:  2016-02-02

10.  Downregulation of microRNA-132 by DNA hypermethylation is associated with cell invasion in colorectal cancer.

Authors:  Jun Qin; Jing Ke; Junfei Xu; Feiran Wang; Youlang Zhou; Yasu Jiang; Zhiwei Wang
Journal:  Onco Targets Ther       Date:  2015-12-07       Impact factor: 4.147

View more
  30 in total

1.  Transcriptomic analysis reveals the role of a peptide derived from CRYAB on the CoCl2-induced hypoxic HL-1 cardiomyocytes.

Authors:  Xiaoshan Hu; Heng Liu; Mengmeng Li; Jingai Zhu; Zhangbin Yu
Journal:  J Thromb Thrombolysis       Date:  2021-02       Impact factor: 2.300

Review 2.  The outstanding role of miR-132-3p in carcinogenesis of solid tumors.

Authors:  Milad Rafat; Mahta Moraghebi; Masoumeh Afsa; Kianoosh Malekzadeh
Journal:  Hum Cell       Date:  2021-05-17       Impact factor: 4.174

3.  MiR-132-3p serves as a tumor suppressor in mantle cell lymphoma via directly targeting SOX11.

Authors:  Baoyu Wu; Jingyu Li; Han Wang; Qian Wu; Hui Liu
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2020-02-10       Impact factor: 3.000

4.  Differentially expressed genes, lncRNAs, and competing endogenous RNAs in Kawasaki disease.

Authors:  Changsheng Guo; Yuanqing Hua; Zuanhao Qian
Journal:  PeerJ       Date:  2021-05-12       Impact factor: 2.984

5.  Effects of miR-132-3p on progress and epithelial mesenchymal transition of non-small cell lung cancer via regulating KLF7.

Authors:  Ning Wang; Ye Xu; Qingkui Guo; Chen Zhu; Wen Zhao; Wenliang Qian; Min Zheng
Journal:  J Thorac Dis       Date:  2021-04       Impact factor: 2.895

6.  Up-regulated lncRNA XIST contributes to progression of cervical cancer via regulating miR-140-5p and ORC1.

Authors:  Xing Chen; Dongsheng Xiong; Liya Ye; Kai Wang; Lingfei Huang; Shuangshuang Mei; Jinhong Wu; Shanshan Chen; Xiaoli Lai; Lingzhi Zheng; Meifen Wang
Journal:  Cancer Cell Int       Date:  2019-02-28       Impact factor: 5.722

7.  LncRNA SNHG5 promotes nasopharyngeal carcinoma progression by regulating miR-1179/HMGB3 axis.

Authors:  Dengtao Liu; Yanpeng Wang; Yigang Zhao; Xiao Gu
Journal:  BMC Cancer       Date:  2020-03-04       Impact factor: 4.430

8.  Integrated whole transcriptome and small RNA analysis revealed multiple regulatory networks in colorectal cancer.

Authors:  Hibah Shaath; Salman M Toor; Mohamed Abu Nada; Eyad Elkord; Nehad M Alajez
Journal:  Sci Rep       Date:  2021-07-14       Impact factor: 4.379

9.  Comprehensive Analysis of Differentially Expressed lncRNAs miRNAs and mRNA and Their ceRNA Network of Patients With Rare-Earth Pneumoconiosis.

Authors:  Xue-Min Shi; Yu-Chao Bai; Yan-Rong Gao; Ning Bu; Hai-Yan Song; Li-Hua Huang; Yu-Hang Zhao; Su-Hua Wang
Journal:  Front Genet       Date:  2021-07-19       Impact factor: 4.599

10.  CREB5 promotes invasiveness and metastasis in colorectal cancer by directly activating MET.

Authors:  Shuyang Wang; Junfeng Qiu; Lei Liu; Cailin Su; Lu Qi; Chengmei Huang; Xiaoning Chen; Yaxin Zhang; Yaping Ye; Yanqing Ding; Li Liang; Wenting Liao
Journal:  J Exp Clin Cancer Res       Date:  2020-08-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.